Targeting Acute
Myelogenous Leukemia Using PotentHuman Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety. The gene discussed is DHODH; the disease is acute myeloid leukemia.